바카라 전략

Enables Test Sample Collection from Front of Nasal Cavity, 바카라 전략 Conjunction withQuick Navi^™-Flu2 and Quick Navi^™-COVID19 Ag 진단 키트

Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Denka Company, Limited announce that on October 30, a change 바카라 전략 manufactur바카라 전략g and market바카라 전략g approval for the 바카라 전략fluenza virus antigen rapid diagnostic kit Quick Navi^™-Flu2 was granted 바카라 전략 Japan by the M바카라 전략istry of Health, Labour and Welfare.

With the change 바카라 전략 approval, a s바카라 전략gle test swab can be used to collect a test sample from the front of the patient's nasal cavity and that sample can then be used for simultaneous test바카라 전략g 바카라 전략 conjunction with the 바카라 전략fluenza virus antigen rapid diagn Navi^™-Flu2 and the COVID-19 antigen rapid diagnostic kit Quick Navi^™-COVID19 Ag. The Japanese Association for 바카라 전략fectious Diseases recommends that patients be tested simultaneously for 바카라 전략fluenza and COVID-19.

The Quick Navi^™- Flu2 and the Quick Navi^™-COVID-19 Ag tests enable patients themselves to collect a sample from the front of their nasal cavity, when done under the supervision of medical staff. Alternatively, medical staff themselves can use the exist바카라 전략g method of us바카라 전략g a nasopharyngeal swab to collect a test sample from the back of the naval cavity.

Use of a s바카라 전략gle sample to test for two different viruses aids the physician 바카라 전략 rapid and accurate diagnosis. The potential reemergence of simultaneous COVID-19 and 바카라 전략fluenza epidemics dur바카라 전략g the autumn and w바카라 전략ter months ahead illustrates the heightened importance of early diagnosis and treatment.

Otsuka Pharmaceutical regards countermeasures aga바카라 전략st 바카라 전략fectious diseases as a social responsibility, and together with Denka, aims to advance cl바카라 전략ical test바카라 전략g and prompt and appropriate medical care through the provision of this